Acadia Realty Trust

  • Earnings Score
  • Moat Score
  • Market Cap $2.66B
  • PE -818
  • Debt $1.59B
  • Cash $69.30M
  • EV $4.18B
  • FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$3.26M
EBIT$59.91M
ROE-0%
ROA1%
Equity$2.37B
Growth Stability-296%
PE-817.6
PEG339.71
PB1.12
P/S7.57
Price/Cash0.03
Debt/Equity0.67
Net Margins3%
Op. Margins17%
Earnings CAGR-2%
Sales Growth YoY8%
Sales Growth QoQ1%
Sales CAGR4%
Equity CAGR3%
Earnings Stability0.06
Earnings Growth YoY-187%
Earnings Growth QoQ675%
Earnings CAGR 5Y-2%
Sales CAGR 5Y6%
Equity CAGR 5Y2%
Earnings CAGR 3Y6%
Sales CAGR 3Y6%
Equity CAGR 3Y-0%
Market Cap$2.66B
Revenue$351.87M
Dividend Yield3%
Payout Ratio-2K%
Assets$4.28B
Total Debt$1.59B
Cash$69.30M
Shares Outstanding104.7M
EV4.18B
Earnings Score6%
Moat Score32%
Shares Growth 3y5%
Equity Growth QoQ6%
Equity Growth YoY12%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

SEC Filings

Direct access to Acadia Realty Trust (AKR) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Acadia Realty Trust compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Acadia Realty Trust compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -2%
Stability 6%
loading chart...

Acadia Realty Trust Discounted Cash Flow

Fully customizable DCF calculator online for Acadia Realty Trust.

0
012345678910TV
fcf$0$0$0$0$0$0$0$0$0$0$0$0
DCF$0$0$0$0$0$0$0$0$0$0$0
Value$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins--38%25%-6%7%-26%8%-20%-1%3%
ROA-2%1%0%1%2%-2%1%2%1%1%
ROE-4%3%3%-1%1%-3%1%-3%-0%-0%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-----------
Debt over Equity0.790.90.690.650.750.790.860.850.830.90.67
Growth Stability---88%-24%54%-296%----296%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth---32%5%13%-13%14%12%4%6%
Earnings YoY growth--8%11%-16%-126%-235%-411%-136%-377%-97%-2%
Equity YoY growth-6%43%2%-6%5%-6%5%1%-4%2%
FCF YoY growth-----------